AACR Chat on Breakthroughs in Cancer Research

Article

Learn about breakthroughs in research and treatments on Twitter from top cancer researchers

For those willing to venture onto Twitter, the American Association for Cancer Research (AACR) and ABC's Dr. Richard Besser will conducting a tweetchat on Tuesday 4/21 at 1 PM ET from the AACR Annual Meeting (AACR 2015). The topic is "Breakthroughs in Cancer Research."

Many top cancer researchers and their institutions participated in last year’s chat from AACR 2014. With nearly 350 participants and over 2000 tweets, the chat moved fast and didn't have time to answer many questions. However, it did offer lots of info about cutting edge cancer basic research and treatments--this is one of the big conferences at which major discoveries are announced. Chat topics will possibly include new genetic targets for drugs, biomarkers that can indicate what type of treatment might work best (as well as whether a treatment is working), and developments regarding immunotherapy, which harness the body’s immune system to fight cancer.

If you haven’t followed a tweetchat before, below is a tweetchat primer (adapted with permission from #LCSM Chat. Hope to see you in the chat!

How do I join the chat on Twitter?

You will need a Twitter account to view or participate in the tweetchat.

Although you can follow this chat using just Twitter, you'll find it much easier to keep up if you use a tweetchat tool. Both methods are described below.

If you just want to watch the tweetchat, you can let other in the chat know you are watching by tweeting "#abcDRBchat" to announce your presence.

The moderator Dr. Besser (@abcDrBchat) will presents topics for discussion and assign each topic a number (T1, T2,T3, etc.). Once he tweets a topic, people respond to it with comments and questions. It helps others track the conversation if you put the topic number at the beginning of your tweet.

To participate in a tweetchat using Twitter:

1. Sign in to your Twitter account.

2. To see ONLY the tweets in the tweetchat (which makes following the conversation much easier), filter your Twitter feed to show only tweets containing the hashtag "#abcDRBchat". To filter your Twitter feed, enter "#abcDRBchat" in the gray box containing the magnifying glass at the top of your Twitter feed--the box is outlined in red for emphasis in the example below. Be sure to click on "All" below the words "Results for #abcDRBchat " -- if you don't click on All, your feed will only show you some (not all) of the tweets containing #abcDRBchat.

how to filter for #LCSM

3. To add your tweets to the chat, include the designated hashtag (in this case "#abcDRBchat") in every tweet you want to be seen in the chat.

To participate in the chat using a tweetchat tool:

You'll find it much easier to follow and participate in the chat by using a tweetchat tool like tchat.io. To do this:

1. Sign in to Twitter. Be sure your Twitter privacy settings allow anyone to see your tweets.

2. Enter the URL "tchat.io" in your browser (or click here to be taken to that URL).

3. Enter "#abcDRBchat" in the box on the screen, and click "Start Chatting"

4. Click on "Sign in to get an in-page tweet box" just below the white box, then click "Authorize App" on the next screen to login to Twitter. You'll then be redirected back to the tchat.io page. This will allow you to type your tweets in the textbox at the top of the page. Tchat.io will automatically add the #abcDRBchat hashtag at the end of your tweet so it will be seen in the chat.

5. Click on "hide retweets" (just below the blue "Tweet" bar). Hiding retweets will make it easier to follow the conversation.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content